Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with (90)Y and (111)In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin’s Lymphoma

BACKGROUND: On the basis of results of our previous investigations on (90)Y-DTPA-rituximab and in order to fulfil national demands to radioimmunoconjugates for radioscintigraphy and radioimmunotherapy of Non-Hodgkin’s Lymphoma (NHL), preparation and radiolabeling of a lyophilized formulation (kit) o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Daru
Главные авторы: Gholipour, Nazila, Jalilian, Amir Reza, Khalaj, Ali, Johari-Daha, Fariba, Yavari, Kamal, Sabzevari, Omid, Khanchi, Ali Reza, Akhlaghi, Mehdi
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4261883/
https://ncbi.nlm.nih.gov/pubmed/25074720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2008-2231-22-58
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы